
Join to View Full Profile
400 S 43rd StRenton, WA 98055
Phone+1 425-690-3585
Dr. Vossler is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- David Vossler, MD, is a neurologist based in North Bend, WA, specializing in epilepsy and clinical neurophysiology.
He completed medical school at Jefferson Medical College in Philadelphia, an internship in internal medicine at Thomas Jefferson University, a neurology residency at Boston University Medical Center, and a fellowship in clinical neurophysiology at the University of Washington in Seattle. Then, Dr. Vossler joined the faculty at the University of Washington and now serves as a Clinical Professor of Neurology.
He served as the Medical Director of the Neuroscience Institute at UW Medicine | Valley Medical Center in Renton Washington, and previously served as Medical Director of the Epilepsy Center and Clinical Neurophysiology Laboratories at Swedish Medical Center.
His clinical expertise includes EEG, clinical neurophysiology and epilepsy.
He has published 115 original research and review articles and book chapters on antiseizure medications, temporal lobe epilepsy, EEG, evoked potentials, Lennox-Gastaut syndrome and other topics.
Dr. Vossler conducted 72 clinical research trials and has participated in the research leading to the approval of 17 antiseizure medications, the responsive neurostimulator, and new approaches to epilepsy surgeries.
Dr. Vossler is on the Board of Directors of the American Epilepsy Society and the Professional Advisory Board of the Epilepsy Foundation Northwest.
He has served on multiple international journals as both contributing editor and peer-reviewer. He consults with multiple international companies conducting research and development of new antiseizure therapies.
Education & Training
University of WashingtonFellowship, Clinical Neurophysiology, 1987 - 1989
Boston University Medical CenterResidency, Neurology, 1984 - 1987
Sidney Kimmel Medical College at Thomas Jefferson University/TJUHInternship, Internal Medicine, 1983 - 1984
Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1983
University of RochesterB.A., Interdepartmental Studies (Biochemistry), Magna Cum Laude, 1975 - 1979
Certifications & Licensure
WA State Medical License 1987 - 2027
MA State Medical License 1984 - 1987
PA State Medical License 1983 - 1984
American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2012, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory EHR Suite, Epic Systems Corporation, 2012, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2014, 2016-2017
Clinical Trials
- Phase 3 Study of Adjunctive Ganaxolone in Adults With Drug-resistant Partial Onset Seizures and Open-label Extension Start of enrollment: 2013 Oct 01
Publications & Presentations
PubMed
- 2 citationsBexicaserin for the treatment of seizures in developmental and epileptic encephalopathies: A phase 1b/2a trial (PACIFIC).Dennis J Dlugos, Ingrid E Scheffer, Jacqueline A French, David G Vossler, Chad Orevillo
Epilepsia. 2026-02-01 - 12 citationsEfficacy and safety of perampanel in patients with seizures associated with Lennox-Gastaut syndrome: A randomized trial.David G Vossler, Brenda E Porter, Ryutaro Kira, Jeehun Lee, Alec Aeby
Epilepsia. 2025-02-01 - 2 citationsLong-term safety and efficacy of adjunctive lacosamide in the treatment of generalized onset tonic-clonic seizures: An open-label extension trial.David G Vossler, Mark Kristof Farkas, Irina Poverennova, Masako Watanabe, Peter Conrath
Epilepsia. 2024-12-01
Journal Articles
- Behavioral adverse effects of tiagabine in clinical practiceVossler DG, Morris GL, Harden C, Montouris G, Faught E, Kanner A, Fix A, French JA, and the PADS group study investigators, Epilepsy & Behavior, 1/1/2013
- Increased neocortex astrocyte density in lateral temporal lobe epilepsyVossler DG, Rostad S, Haltiner AM, Davis B, Powell TW, Bell A, Kraemer DLA, J. Clinical Neurophysiology, 1/1/2012
- Early surgical therapy for drug-resistant temporal lobe epilepsy: A randomized trialEngel J Jr, McDermott MP, Wiebe S, Langfitt J, Stern JM, Dewar S et al for the ERSET study group (Vossler DG), JAMA, 1/1/2012
Press Mentions
Arrhythmia Risk of Lamotrigine Questioned by Observational DataDecember 10th, 2024
Upcoming Life Sciences EventsNovember 25th, 2024
Professional Memberships
- Fellow
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









